TopicNeuroscience

optogenetic therapy

Content Overview
4Total items
2Seminars
2ePosters

Latest

SeminarNeuroscienceRecording

Genetic-based brain machine interfaces for visual restoration

Serge Picaud
Institute Vision Paris
Apr 13, 2022

Visual restoration is certainly the greatest challenge for brain-machine interfaces with the high pixel number and high refreshing rate. In the recent year, we brought retinal prostheses and optogenetic therapy up to successful clinical trials. Concerning visual restoration at the cortical level, prostheses have shown efficacy for limited periods of time and limited pixel numbers. We are investigating the potential of sonogenetics to develop a non-contact brain machine interface allowing long-lasting activation of the visual cortex. The presentation will introduce our genetic-based brain machine interfaces for visual restoration at the retinal and cortical levels.

SeminarNeuroscienceRecording

Visual restoration from prosthesis to optogenetic therapy

Serge Picaud
Institut de la Vision
Jun 8, 2021
ePosterNeuroscience

OPTOGENETIC THERAPY TO TREAT SPASTICITY IN A MOUSE MODEL OF SPINAL CORD INJURY

Vasilieos Patsourakos, Steven Ceto, Sriparna Ghosal, Luca R. Liebi, Ivana Gantar, Samira Osterop, Domitille Rajot, Dominik Friedli, Aaron Egounlety, Gregoire Courtine, Jocelyne Bloch, Thomas H. Hutson

FENS Forum 2026

ePosterNeuroscience

OPTOGENETIC THERAPY FOR INHIBITION OF MUSCLE SPASMS AND HYPERREFLEXIA AFTER SPINAL CORD INJURY

Steven Ceto, Vasileios Patsourakos, Luca Liebi, Sriparna Ghosal, Kangling Lu, Ivana Gantar, Stéphanie Lacour, Thomas H. Hutson

FENS Forum 2026

optogenetic therapy coverage

4 items

Seminar2
ePoster2

Share your knowledge

Know something about optogenetic therapy? Help the community by contributing seminars, talks, or research.

Contribute content
Domain spotlight

Explore how optogenetic therapy research is advancing inside Neuroscience.

Visit domain

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.